REVA to Hold Briefing Call on Q3 2015 Financial Results
November 05, 2015 21:36 ET
|
REVA Medical Inc
SAN DIEGO, Nov. 05, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold a conference call to discuss the Company’s financial results through September 30,...
REVA Releases Positive Initial Results for Fantom at TCT 2015
October 15, 2015 18:21 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 15, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that Dr. J. Ribamar Costa from the Institute Dante Pazzanese of...
REVA’s Fantom Scaffold Presented at TCT 2015 Next-Generation Session
October 14, 2015 22:30 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 14, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) is pleased to announce that Dr. J. Ribamar Costa, from the Institute Dante Pazzanese of...
REVA Completes Clinical Enrollment Milestone
September 30, 2015 21:08 ET
|
REVA Medical Inc
SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) is pleased to announce that it has enrolled the first cohort of 110 patients in the FANTOM II clinical trial. Achievement...
REVA Appoints Regina Groves as Chief Executive Officer
August 20, 2015 20:26 ET
|
REVA Medical Inc
SAN DIEGO, Aug. 20, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) is pleased to announce the appointment of Regina Groves as its Chief Executive Officer, effective September 21, 2015. Ms....
REVA to Hold Briefing Call on Q2 2015 Financial Results
August 06, 2015 11:31 ET
|
REVA Medical Inc
SAN DIEGO, Aug. 06, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold its quarterly briefing call to discuss operations and financial results through June...
REVA Releases Initial Clinical Results for Fantom Scaffold
May 21, 2015 19:26 ET
|
REVA Medical Inc
SAN DIEGO, May 21, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") released initial clinical data on a subset of patients treated with the Fantom sirolimus-eluting...
REVA to Present at EuroPCR 2015
May 18, 2015 05:08 ET
|
REVA Medical Inc
SAN DIEGO, May 18, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that Dr. Alexandre Abizaid, Director of Invasive Cardiology at the Institute...
REVA Expands FANTOM II Clinical Trial to Australia
May 14, 2015 20:28 ET
|
REVA Medical Inc
SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that the FANTOM II clinical trial is now enrolling patients with the...
Details for REVA's Annual General Meeting of Stockholders
May 14, 2015 20:13 ET
|
REVA Medical Inc
SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold is 2015 Annual General Meeting of Stockholders (the "AGM") on Wednesday, May 27, 2015 at...